Search - tctmd.com

Displaying 1 - 20 of 83

Sort: Relevancy | Date

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Daily News

PREDIMED Analysis May Rekindle Hope for Wine’s Heart Benefits

Michael O'Riordan

December 18, 2024

News Daily News

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

Michael O'Riordan

December 06, 2024

News Conference News AHA 2024

ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS

Michael O'Riordan

November 21, 2024

News Conference News AHA 2024

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

Michael O'Riordan

November 18, 2024

News Conference News AHA 2024

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Michael O'Riordan

November 17, 2024

News Conference News AHA 2024

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

Michael O'Riordan

November 15, 2024

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

Presentation TCT 2024

TCT 754: Native Coronary Artery Instead of Saphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions (“NASA” Registry)

Presenter: Michaella Alexandrou

October 30, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

TCT 493: Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in Patients With Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Controlled Trials

Presenter: Michael Sabina

October 29, 2024

Presentation TCT 2024

TCT 422: Preclinical Assessment of a Novel Polymer-Free Hybrid Drug-Eluting Stent

Presenter: Michael Joner

October 29, 2024

Presentation TCT 2024

My Personal Guide to Prevention and Management of Equipment Disasters

Presenter: R. Michael Wyman

October 29, 2024

Presentation TCT 2024

What’s Next in Acute and Chronic Phase Antithrombotic Therapy in ACS

Presenter: C. Michael Gibson

October 28, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

Presentation TCT 2024

ORBITA2-PHYSIOLOGY: Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease

Presenter: Michael Foley

October 27, 2024

Presentation TCT 2024

TCT 552: Impact of Calcium on the Long-Term Outcomes of Bifurcation Percutaneous Coronary Intervention (PROGRESS-BIFURCATION)

Presenter: Michaella Alexandrou

October 27, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Daily News

Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction

Todd Neale

October 15, 2024

News Daily News

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

Michael O'Riordan

October 14, 2024

Advertisement

Top Coronary Artery Disease News in 2024

PREDIMED Analysis May Rekindle Hope for Wine’s Heart Benefits

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

TCT 754: Native Coronary Artery Instead of Saphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions (“NASA” Registry)

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

TCT 493: Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in Patients With Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Controlled Trials

TCT 422: Preclinical Assessment of a Novel Polymer-Free Hybrid Drug-Eluting Stent

My Personal Guide to Prevention and Management of Equipment Disasters

What’s Next in Acute and Chronic Phase Antithrombotic Therapy in ACS

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

ORBITA2-PHYSIOLOGY: Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease

TCT 552: Impact of Calcium on the Long-Term Outcomes of Bifurcation Percutaneous Coronary Intervention (PROGRESS-BIFURCATION)

What’s Going to Be Big at TCT 2024?

Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content